AKT1 and neoplasm: Subsequently, PRKCA has been shown to intersect with the MAPK/ERK and PI3K/AKT pathways, which are frequently active in several cancer types, promoting tumor progression by suppressing apoptosis and inducing proliferation, migration, invasion and angiogenesis [38,39,40,41,42,43,44].